Skip to main content

Perspective Therapeutics Inc

For the period ended Mar 31, 2024. Filed May 15, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 15, 2024

CATX$0.84+6.5%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

PART I · FINANCIAL INFORMATION
Item 1Financial Statements1
Condensed Consolidated Balance Sheets as of March 31, 2024 (unaudited) and December 31, 20231
Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023 (unaudited)3
Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2024 and 2023 (unaudited)4
Condensed Consolidated Statements of Changes in Stockholders' Equity for the three months ended March 31, 2024 and 2023 (unaudited)5
Notes to the Unaudited Condensed Consolidated Financial Statements6
Item 2Management’s Discussion and Analysis of Financial Condition and Results of Operations17
Item 3Quantitative and Qualitative Disclosures About Market Risk24
Item 4Controls and Procedures24
PART IIOTHER INFORMATION
Item 1Legal Proceedings25
Item 1ARisk Factors25
Item 2Unregistered Sales of Equity Securities and Use of Proceeds25
Item 3Defaults Upon Senior Securities25
Item 4Mine Safety Disclosures25
Item 5Other Information25
Item 6Exhibits26
Signatures28

ii

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.